Insider filing · ECAT

BlackRock, Inc. bought $1.4M of BlackRock ESG Capital Allocation Term (ECAT)

Executed Mar 14 2025, disclosed Mar 14 2025, the same day.

Over the 21 trading sessions from the disclosed entry session (Mar 14 2025), the stock returned -6.6% (delay-adjusted); from the execution session (Mar 14 2025), -6.6%. Derived: entry at the session's open, exit at the close 20 sessions later.

BI BlackRock, Inc. Other profile →

BlackRock, Inc. (Other) filed 15 Form 4 reports as a reporting entity in the past 24 months (15 purchases, 0 sales), most often in BlackRock ESG Capital Allocation Term Trust (ECAT). Across 14 priced purchase filings, the average 21-session return was -7.8% from execution and -8.0% from disclosure (delay-adjusted; derived). The largest single filing was $1.7M of ECAT (101,600 sh × $16.31, as filed), executed Mar 20 2025.

ECAT BlackRock ESG Capital Allocation Term Trust ECAT · 140 filings in 24 months ticker →

Financial Services

Insider filings, newest first→ View the original filing at www.sec.gov→